{"protocolSection":{"identificationModule":{"nctId":"NCT04947124","orgStudyIdInfo":{"id":"QC-203"},"organization":{"fullName":"Qlaris Bio, Inc.","class":"INDUSTRY"},"briefTitle":"A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101","officialTitle":"Masked, Randomized, Single-site, Crossover Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 Dosed for 14 Days in Adult Subjects With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-10-19","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-06-06","type":"ACTUAL"},"completionDateStruct":{"date":"2022-08-01","type":"ACTUAL"},"studyFirstSubmitDate":"2021-06-08","studyFirstSubmitQcDate":"2021-06-23","studyFirstPostDateStruct":{"date":"2021-07-01","type":"ACTUAL"},"dispFirstSubmitDate":"2023-03-21","dispFirstSubmitQcDate":"2023-03-22","dispFirstPostDateStruct":{"date":"2023-03-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-22","lastUpdatePostDateStruct":{"date":"2023-03-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Qlaris Bio, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Safety and tolerability study of 2 concentrations of QLS-101 for adult subjects with Sturge Weber Syndrome (SWS)-related glaucoma due to elevated episcleral venous pressure (EVP).","detailedDescription":"Masked, randomized, single site, crossover study to compare 2 concentrations of QLS-101. Subjects will be randomized to one of 2 concentrations of QLS-101 for the first 14 days of daily dosing, and after a 14-day washout period they will be crossed over to the other concentration for another 14 days of daily dosing. Dose assignment is masked to patient and investigator."},"conditionsModule":{"conditions":["Sturge-Weber Syndrome (SWS)","Glaucoma","Glaucoma Congenital","Ocular Hypertension"],"keywords":["Sturge-Weber Syndrome","Glaucoma","Elevated Intraocular pressure (IOP)"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","interventionModelDescription":"Patients take 2 different doses of investigational product at distinct treatment periods. Dose is masked.","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","maskingDescription":"Masked investigational product labeling.","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":3,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1% QLS-101","type":"EXPERIMENTAL","description":"dosed once a day for 14 days as either first or second dosing period per randomization","interventionNames":["Drug: QLS-101ophthalmic solution 1%"]},{"label":"2% QLS-101","type":"EXPERIMENTAL","description":"dosed once a day for 14 as either first or second dosing period per randomization","interventionNames":["Drug: QLS-101ophthalmic solution 2%"]}],"interventions":[{"type":"DRUG","name":"QLS-101ophthalmic solution 1%","description":"QLS-101ophthalmic solution 1.0%","armGroupLabels":["1% QLS-101"],"otherNames":["QLS-101"]},{"type":"DRUG","name":"QLS-101ophthalmic solution 2%","description":"QLS-101ophthalmic solution 2.0%","armGroupLabels":["2% QLS-101"],"otherNames":["QLS-101"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Ocular adverse events (AEs)","description":"Standard safety endpoint, ocular AEs, (including elevated IOP)","timeFrame":"56 days, including a 14-day washout"},{"measure":"Visual acuity","description":"Standard safety endpoint, best corrected visual acuity, Snellen score, change from baseline","timeFrame":"56 days, including a 14-day washout"},{"measure":"Enhance depth imaging optical coherence tomography (EDI-OCT)","description":"Standard safety endpoint, EDI-OCT, corneal thickness","timeFrame":"56 days, including a 14-day washout"},{"measure":"Slit lamp exam","description":"Standard safety endpoint, slit lamp exam, abnormalities, changes from baseline","timeFrame":"56 days, including a 14-day washout"},{"measure":"Dilated fundus exam","description":"Fundus exam, abnormalities, changes from baseline","timeFrame":"56 days, including a 14-day washout"}],"secondaryOutcomes":[{"measure":"Ocular hypotensive efficacy","description":"Mean change in IOP from baseline following 14 days dosing","timeFrame":"14 days after each dosing timepoint is completed"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed with SWS.\n* Elevated intraocular pressure (IOP)\n* Willing to continue current dosing regimen of IOP-lowering medications\n* Willing to refrain from contact lens use in the study eye.\n\nExclusion Criteria:\n\n* IOP with variability of \\> 4 mm Hg\n* Expected to undergo IOP-lowering surgery\n* Incisional or laser surgery of any type\n* Ocular infection, inflammation, clinically significant blepharitis or conjunctivitis\n* A history of herpes simplex keratitis in either eye.\n* History of or active clinically significant ocular disease\n* Use of topical ocular corticosteroids in the 6 weeks prior to Visit 1","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"B. Wirostko, M.D.","affiliation":"Qlaris Bio, Inc.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Duke Eye Center","city":"Durham","state":"North Carolina","zip":"27710","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}}]},"referencesModule":{"seeAlsoLinks":[{"label":"Qlaris Bio website, pipeline page","url":"https://qlaris.bio"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000013341","term":"Sturge-Weber Syndrome"},{"id":"D000020526","term":"Brain Stem Infarctions"},{"id":"D000005901","term":"Glaucoma"},{"id":"D000009798","term":"Ocular Hypertension"},{"id":"D000006871","term":"Hydrophthalmos"},{"id":"D000007715","term":"Klippel-Trenaunay-Weber Syndrome"},{"id":"D000013577","term":"Syndrome"}],"ancestors":[{"id":"D000004194","term":"Disease"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000005128","term":"Eye Diseases"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000007238","term":"Infarction"},{"id":"D000007511","term":"Ischemia"},{"id":"D000009336","term":"Necrosis"},{"id":"D000000798","term":"Angiomatosis"},{"id":"D000006391","term":"Hemangioma"},{"id":"D000009383","term":"Neoplasms, Vascular Tissue"},{"id":"D000009370","term":"Neoplasms by Histologic Type"},{"id":"D000009369","term":"Neoplasms"},{"id":"D000020752","term":"Neurocutaneous Syndromes"},{"id":"D000005124","term":"Eye Abnormalities"},{"id":"D000005902","term":"Glaucoma, Open-Angle"},{"id":"D000000013","term":"Congenital Abnormalities"},{"id":"D000007232","term":"Infant, Newborn, Diseases"}],"browseLeaves":[{"id":"M9714","name":"Hypertension","relevance":"LOW"},{"id":"M16045","name":"Syndrome","asFound":"Syndrome","relevance":"HIGH"},{"id":"M8703","name":"Glaucoma","asFound":"Glaucoma","relevance":"HIGH"},{"id":"M12421","name":"Ocular Hypertension","asFound":"Ocular Hypertension","relevance":"HIGH"},{"id":"M9616","name":"Hydrophthalmos","asFound":"Glaucoma Congenital","relevance":"HIGH"},{"id":"M10425","name":"Klippel-Trenaunay-Weber Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"M15821","name":"Sturge-Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M22001","name":"Brain Stem Infarctions","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M7961","name":"Eye Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M3816","name":"Angiomatosis","relevance":"LOW"},{"id":"M9169","name":"Hemangioma","relevance":"LOW"},{"id":"M12018","name":"Neoplasms, Vascular Tissue","relevance":"LOW"},{"id":"M12005","name":"Neoplasms by Histologic Type","relevance":"LOW"},{"id":"M22199","name":"Neurocutaneous Syndromes","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M7957","name":"Eye Abnormalities","relevance":"LOW"},{"id":"M8704","name":"Glaucoma, Open-Angle","relevance":"LOW"},{"id":"M9966","name":"Infant, Newborn, Diseases","relevance":"LOW"},{"id":"T2512","name":"Glaucoma, Congenital","asFound":"Glaucoma Congenital","relevance":"HIGH"},{"id":"T3248","name":"Klippel-Trenaunay Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"T4428","name":"Parkes Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"},{"id":"T5905","name":"Weber Syndrome","asFound":"Weber Syndrome","relevance":"HIGH"},{"id":"T5493","name":"Sturge-Weber Syndrome","asFound":"Sturge-Weber Syndrome","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC11","name":"Eye Diseases"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC17","name":"Skin and Connective Tissue Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000019999","term":"Pharmaceutical Solutions"},{"id":"D000009883","term":"Ophthalmic Solutions"}],"browseLeaves":[{"id":"M12504","name":"Ophthalmic Solutions","asFound":"Alfa","relevance":"HIGH"},{"id":"M21550","name":"Pharmaceutical Solutions","asFound":"From","relevance":"HIGH"}],"browseBranches":[{"abbrev":"PhSol","name":"Pharmaceutical Solutions"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}